These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37608073)

  • 1. A simplified mesoscale 3D model for characterizing fibrinolysis under flow conditions.
    Petkantchin R; Rousseau A; Eker O; Zouaoui Boudjeltia K; Raynaud F; Chopard B;
    Sci Rep; 2023 Aug; 13(1):13681. PubMed ID: 37608073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate.
    Weisel JW; Litvinov RI
    Cardiovasc Hematol Agents Med Chem; 2008 Jul; 6(3):161-80. PubMed ID: 18673231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood clot contraction differentially modulates internal and external fibrinolysis.
    Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
    J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
    Wootton DM; Popel AS; Alevriadou BR
    Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin Network Formation and Lysis in Septic Shock Patients.
    Larsen JB; Aggerbeck MA; Larsen KM; Hvas CL; Hvas AM
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
    Wu JH; Siddiqui K; Diamond SL
    Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions.
    Huang TC; Jordan RE; Hantgan RR; Alevriadou BR
    Thromb Res; 2001 Jun; 102(5):411-25. PubMed ID: 11395127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redistribution of TPA Fluxes in the Presence of PAI-1 Regulates Spatial Thrombolysis.
    Shibeko AM; Chopard B; Hoekstra AG; Panteleev MA
    Biophys J; 2020 Aug; 119(3):638-651. PubMed ID: 32653051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic Modeling of Thrombolysis.
    Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
    Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherent fibrin fiber tension propels mechanisms of network clearance during fibrinolysis.
    Cone SJ; Fuquay AT; Litofsky JM; Dement TC; Carolan CA; Hudson NE
    Acta Biomater; 2020 Apr; 107():164-177. PubMed ID: 32105833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased von Willebrand factor, P-selectin and fibrin content in occlusive thrombus resistant to lytic therapy.
    Sambola A; García Del Blanco B; Ruiz-Meana M; Francisco J; Barrabés JA; Figueras J; Bañeras J; Otaegui I; Rojas A; Vilardosa Ú; Montaner J; García-Dorado D
    Thromb Haemost; 2016 Jun; 115(6):1129-37. PubMed ID: 26962963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
    Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
    Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and Physical Mechanisms of Fibrinolysis and Thrombolysis from Mathematical Modeling and Experiments.
    Bannish BE; Chernysh IN; Keener JP; Fogelson AL; Weisel JW
    Sci Rep; 2017 Aug; 7(1):6914. PubMed ID: 28785035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling fibrinolysis: 1D continuum models.
    Bannish BE; Keener JP; Woodbury M; Weisel JW; Fogelson AL
    Math Med Biol; 2014 Mar; 31(1):45-64. PubMed ID: 23220467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
    Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy.
    Sakharov DV; Nagelkerke JF; Rijken DC
    J Biol Chem; 1996 Jan; 271(4):2133-8. PubMed ID: 8567670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of flow on lysis of plasma clots in a plasma environment.
    Sakharov DV; Rijken DC
    Thromb Haemost; 2000 Mar; 83(3):469-74. PubMed ID: 10744155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.